Editorial Note: Neal Parker, Section Head Legal, Biologics Strategic Development at AbbVie, was an industry representative on a panel organized by EFPIA - The European Federation of Pharmaceutical Industries and Associates on August 27th in Bruxelles. Parker started off with a wonderful Freudian slip saying that AbbVie's mission is to discover new diseases. A video of the … [Read more...] about Neal Parker on AbbVie’s Mission to Discover New Diseases
Blog
Trade Wars we have known and loved: Indianapolis v The World
Several weeks ago Canadians woke up to a Globe and Mail article saying that the pharmaceutical company Eli Lilly, who are based in Indianapolis, was suing their Government for $500 million for loss of revenues linked to the loss of patents on two of its drugs - Zyprexa and Strattera. "The drug giant alleges that the loss of its patents violates Canada’s obligations under … [Read more...] about Trade Wars we have known and loved: Indianapolis v The World
Trade Wars we have known and loved: AbbVie v China
Editorial Note: This post is taken from a more complete article published in BMJ today authored by Nigel Hawkes. It tells of a recent European meeting on access to clinical trial data. The meeting had input from AbbVie who it seems shocked everyone in the room shocked with their disregard for patient safety. The details here make it very clear why we need to petition AbbVie … [Read more...] about Trade Wars we have known and loved: AbbVie v China
AbbVie Petition: Drug Hazards are not Trade Secrets
RxISK has started a petition on Change.org which will go to Richard Gonzalez CEO of AbbVie, and Daniel Welch CEO of InterMune, who are at present taking a legal action to block the European Medicines Agency's policy of open access to clinical trial data. The reason to petition is in this post Let's do the AbbVie again and the Petition is Here. Can you take 30 seconds to … [Read more...] about AbbVie Petition: Drug Hazards are not Trade Secrets
Humira & Hope – and Despair: Annette’s Story
Editorial Note: Many people have wonderful responses to Humira and other biologic drugs like Enbrel (Phil Mickelson in the case of Enbrel). Rheumatoid Arthritis, Crohn's Disease and the other conditions these drugs were first used for are debilitating disorders that need a potent treatment. But if a drug is potent it will have the capacity to cause significant harms. Lots of … [Read more...] about Humira & Hope – and Despair: Annette’s Story
The Humira Trials: Judith’s Story
Editorial Note: AbbVie's current legal action against the European Medicines Agency's policy on access to clinical trial data led to the idea of an AbbVie - getting people on any drugs at all, especially new drugs and in particular biologicals, to do two things: 1. Report any of the effects they are having on RxISK.org 2. Sign the petition below AbbVie applied to block … [Read more...] about The Humira Trials: Judith’s Story
Stacy London: What Not To Take
Three weeks ago Johanna Ryan and Kim Witczak wrote a letter to Stacy London about Humira and AbbVie. They were hoping for a response but there has been none so far. There’s something about Stacy Stacy London of What Not to Wear fame has a lot going for her. She is a successful business woman, style guru and role model for women around the world. AbbVie must be delighted to … [Read more...] about Stacy London: What Not To Take
Welcome to the Humiraverse
Editorial Note: This post in the AbbVie series is by Johanna Ryan from the RxISK Community Advisory Board I recently read a legal complaint filed against AbbVie by a New York woman named Cynthia Di Bartolo. She’s a successful corporate lawyer who had undergone various treatments for psoriasis over the years, including medications and ultraviolet light therapy. In November 2008 … [Read more...] about Welcome to the Humiraverse
Democracy in Adversity
This post stands in stark contrast to EU-nuch in the Humira-m. There could not be a greater contrast between the way companies now sell drugs globally and the way they attempt to restrict the reporting of adverse events. The infographic below from Kayla brings out the point. Sales are now global. AbbVie's plans for Humira and the plans other companies have for their … [Read more...] about Democracy in Adversity
EU-nuch in the Humira-m
No such thing as being 'European' There is no such thing as being European when you take a drug like Humira or Depakote and something goes wrong. When something goes wrong on their drug, companies go to extraordinary lengths to make it almost impossible for doctors or patients to report adverse events. It’s part of a larger mission to transform what were poisons to be used … [Read more...] about EU-nuch in the Humira-m